News & Alerts
-
Nov- 2021 -10 November
Why Pharmacies Are Refusing To Stock Buprenorphine
The Drug Enforcement Administration’s approach to buprenorphine regulation is exacerbating the opioid epidemic by unnecessarily discouraging pharmacies from dispensing the drug,…
Read More » -
9 November
Avoid This Antidepressant When Treating Dementia-Study
A drug used to treat agitation in people with dementia is no more effective than a placebo, and might even…
Read More » -
8 November
Molnupiravir: 5 Things to Know About the World’s 1st COVID Pill
Molnupiravir, made by Merck and a Florida-based biotech called Ridgeback Biotherapeutics, is the first oral antiviral medicine available to treat…
Read More » -
8 November
Cancer Drugs: Push For US-China Collaboration Begins
According to a report by the Financial Times, global drug-makers, regulatory officials and scientists are teaming up to push the…
Read More » -
8 November
HLB’s Liver Cancer Drug Gets FDA’s Orphan Drug Status
According to reports, HLB’s anticancer drug candidate rivoceranib has won an orphan drug designation from the U.S. Food and Drug…
Read More » -
7 November
US Offers $5m Bounty For Info on Mexican Drug Cartels
According to reports, the United States State Department has announced rewards of up to $5m each for information that will…
Read More » -
7 November
Keytruda Set To Become Top-Selling Drug in The World
According to reports, Merck’s cancer drug Keytruda is catching up to AbbVie’s Humira as the highest selling drug in the…
Read More » -
5 November
Pfizer COVID Vaccine For Children 5 Things You Should Know
The Centers for Disease Control and Prevention, the national public health agency of the United States through its Director Rochelle…
Read More » -
4 November
New Drug Unblock & Normalize Blood Vessels in Cancerous Tumors
A therapeutic antibody developed by scientists at University College London has been shown to unblock and normalize blood vessels inside…
Read More » -
4 November
Demand for Novo Nordisk’s Wegovy Outstripping Supply
According to a report by Bloomberg, the demand for Novo Nordisk’s Wegovy, the first new obesity drug approved in seven…
Read More »